Overview

Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects

Status:
Completed
Trial end date:
2018-11-15
Target enrollment:
Participant gender:
Summary
The objective of this exploratory study is to determine the safety and efficacy of 0.002% Naltrexone Ophthalmic Solution, compared to placebo for the treatment of the signs and symptoms of dry eye in diabetic subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Eugene B. McLaurin, M.D., F.A.C.S.
Treatments:
Naltrexone
Ophthalmic Solutions
Pharmaceutical Solutions